Synthesis and characterization of rhenium and technetium-99m labeled insulin

Journal of Medicinal Chemistry

Volumn 53, Issue 6, 2010, Pages 2612-2621

  Sundararajan, Chitra ^a   Besanger, Travis R ^a   Labiris, Renee ^a   Guenther, Katharina J ^a   Strack, Thomas ^b   Garafalo, Robert ^b   Kawabata, Thomas T ^b   Finco Kent, Deborah ^b   Zubieta, Jon ^c   Babich, John W ^d   Valliant, John F ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b PFIZER INC   (United States)

^c SYRACUSE UNIVERSITY   (United States)

^d Clinical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANISOLE; INSULIN RE; INSULIN RECEPTOR; INSULIN TC 99M; IODINE 125; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CONTROLLED STUDY; DEPROTECTION REACTION; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; INSULIN; MODELS, CHEMICAL; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; RHENIUM; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TECHNETIUM;

EID: 77949823717     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm100096c     Document Type: Article

References (36)

1. Saltiel, A. R.; Kahn, C. R. Insulin Signalling and the Regulation of Glucose and Lipid Metabolism. Nature 2001, 414, 799-806.
2. DeFronzo, R. A. Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidaemia and Atherosclerosis. Neth. J. Med. 1997, 50, 191-197.
3. Kaaks, R.; Toniolo, P.; Akhmedkhanov, A.; Lukanova, A.; Biessy, C.; Decaud, H.; Rinaldi, S.; Zeleniuch-Jacquotte, A.; Shore, R. E.; Riboli, E. Serum C-Peptide, Insulin-like Growth Factor (IGF)-I, IGF-Binding Proteins, and Colorectal Cancer Risk in Women. J. Natl. Cancer Inst. 2000, 92, 1592-1600.
4. Wajchenberg, B. L.; Pinto, H.; Torres de Toledo e Souza, I.; Lerário, A. C.; Pieroni, R. R. Preparation of Iodine-125-Labeled Insulin for Radioimmunoassay: Comparison of Lactoperoxidase and Chloramine-T Iodination. J. Nucl. Med. 1978, 19, 900-905.
5. 125I]-(Tyr A19)- Insulin. Diabetologica 1980, 19, 546-554.
6. 125I for Use in Receptor Binding Experiments by High-Performance Liquid Chromatography. J. Chromatograph., Biomed. Appl. 1996, 579, 21-29.
7. 14-Iodoinsulin as a Radiotracer for Positron Emission Tomography. J. Labelled Compd. Radiopharm. 2001, 44, 465-480.
8. Iozzo, P.; Osman, S.; Glaser, M.; Knickmeier, M.; Ferrannini, E.; Pike, V. W.; Camici, P. G.; Law, M. P. In Vivo Imaging of Insulin Receptors by PET: Preclinical Evaluation of Iodine-125 and Iodine-124 Labelled Human Insulin. Nucl. Med. Biol. 2002, 29, 73-82.
9. 18F-Labelled Insulin and Positron Emission Tomography. Diabetes 1992, 41, 855-860.
10. 19F-Labeled Insulin: A New Radiotracer for PET-Based Molecular Imaging Studies. J. Med. Chem. 2006, 49, 1466-1474.
11. 123I]Insulin Scanning. J. Clin. Endocrinol. Metab. 1987, 64, 801-808.
12. Dozio, N.; Scavini, M.; Beretta, A.; Sarugeri, E.; Sartori, S.; Belloni, C.; Dosio, F.; Savi, A.; Fazio, F.; Sodoyez, J. C.; Pozza, G. Imaging of the Buffering Effect of Insulin Antibodies in the Autoimmune Hypoglycemic Syndrome. J. Clin. Endocrinol. Metab. 1998, 83, 643-648.
13. 123I-Insulin Scintigraphic Scanning and in Vitro Characterization in Autoimmune Hypoglycemia. J. Invest. Med. 2001, 49, 85-92.
14. Kurtaran, A.; Li, S.-R.; Raderer, M.; Leimer, M.; Müller, C.; Pidlich, J.; Neuhold, N.; Hübsch, P.; Angelberger, P.; Scheithauer, W.; Virgolini, I. Technetium-99m-galactosyl-neoglycoalbumin Combined with Iodine-123-Tyr-(A14)-Insulin Visualizes Human Hepatocellular Carcinomas. J. Nucl. Med. 1995, 36, 1875-1881.
15. 67Ga]-insulin for insulin receptor imaging. Nucl. Med. Rev. Cent. East Eur. 2007, 10, 71-75.
16. Jalilian, A. R.; Garousi, J.; Gholami, E.; Akhlaghi, M Bolourinovin, F.; Rajabifar, S. Preparation and biodistribution of [Ga]-insulin for SPECT purposes. Nukleonika 2007, 52, 145-151.
17. Hnatowich, D. J.; Layne, W. W.; Childs, R. L.; Lanteigne, D.; Davis, M. A.; Griffin, T. W.; Doherty, P. W. Radioactive labeling of antibody: a simple and efficient method. Science 1983, 220, 613-615.
18. Nicolini, M.; Bandoli, G.; Mazzi, U. Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine; S. G. Editoriali: Padova, Italy, 2000.
19. Jurisson, S. S.; Lydon, J. D. Potential Technetium Small Molecule Radiopharmaceuticals. Chem. Rev. 1999, 99, 2205-2218.
20. 99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals. Chem. Rev. 1999, 99, 2235-2268.
21. Eckelman, W. C Radiolabeling with Tc-99m to Study HighCapacity and Low-Capacity Biochemical Systems. Eur. J. Nucl. Med. 1995, 22, 249-263.
22. 99mTc-Insulin: Labeling, Biodistribution and Scintiimaging in Animals. Nucl. Med. Biol. 1994, 21, 251-254.
23. 99mTc Complexes for Correlating Fluorescence and Radioimaging Studies. J. Am. Chem. Soc. 2004, 126, 8598-8599.
24. +]G. Bioconjugate Chem. 2004, 15, 128-136.
25. Gliemann, J.; Gammeltoft, S. The Biological Activity and the Binding Affinity of Modified Insulins Determined on Isolated Rat Fat Cells. Diabetologica 1974, 10, 105-113.
26. Murray-Rust, J.; McLeod, A. N.; Blundell, T. L.; Wood, S. P. Structure and Evolution of Insulins: Implications for Receptor Binding. BioEssays 1992, 14, 325-331.
27. Shai, Y.; Kirk, K. L.; Channing, M. A.; Dunn, B. B.; Lesniak, M. A.; Eastman, R. C.; Finn, R. D.; Roth, J.; Jacobson, K. A. Fluorine-18 Labeled Insulin: A Prosthetic Group Methodology for Incorporation of a Positron Emitter into Peptides and Proteins. Biochemistry 1989, 28, 4801-4806.
28. Baudys, M.; Uchio, T.; Mix, D.; Wilson, D.; Kim, S. W. Physical Stabilization of Insulin by Glycosylation. J. Pharm. Sci. 1995, 84, 28-33.
29. + Cores. Inorg. Chem. 2002, 41, 6417-6425.
30. Causey, P. W.; Besanger, T. R.; Schaffer, P.; Valliant, J. F. Expedient Multi-Step Synthesis of Organometallic Complexes of Tc and Re in High Effective Specific Activity. A New Platform for the Production of Molecular Imaging and Therapy Agents. Inorg. Chem. 2008, 47, 8213-8221.
31. Lundt, B. F.; Johansen, N. L.; Voelund, A.; Markussen, J. Removal of tert-Butyl and t-Butoxycarbonyl Protecting Groups with Trifluoroacetic Acid. Mechanisms, Byproduct Formation and Evaluation of Scavengers. Int. J. Pept. Protein Res. 1978, 12, 258-268.
32. 99mTc(I)Tricarbonyl Complexes: A Hint for the Future Functionalization of Biomolecules. Bioconjugate Chem. 2000, 11, 345-351.
33. + Lisinopril Complexes for in Vivo Imaging of Angiotensin-Converting Enzyme Expression. J. Nucl. Med. 2008, 49, 970-977.
34. 2]Br. Inorg. Chem. Commun. 2004, 7, 1023-1026.
35. Ebina, Y.; Edery, M.; Ellis, L.; Standring, D.; Beaudoin, J.; Roth, R. A.; Rutter, W. J. Expression of a Functional Human Insulin Receptor from a Cloned cDNA in Chinese Hamster Ovary Cells. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 8014-8018.
36. Marin-Hincapie, M.; Garofalo, R. S. The Carboxyl Terminal Extension of the Drosophila Insulin Receptor Homologue Binds IRS-1 and Influences Cell Survival. J. Biol. Chem. 1999, 274, 24987-24994.